View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Optometry News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 03, 2024
3 min watch
Save

VIDEO: Wave-guided optics application helps patients ‘beyond their refractive error’

VIDEO: Wave-guided optics application helps patients ‘beyond their refractive error’

NASHVILLE, Tenn. — Wave-guided optics application technology may now help patients with keratoconus, according to a speaker at Optometry’s Meeting.

SPONSORED CONTENT
July 02, 2024
1 min read
Save

Alcon acquires Belkin Vision, direct selective laser trabeculoplasty device

Alcon acquires Belkin Vision, direct selective laser trabeculoplasty device

Alcon completed the acquisition of Belkin Vision, including its direct selective laser trabeculoplasty technology, according to a press release.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
July 02, 2024
3 min read
Save

Q&A: Optometrists ‘on the frontlines’ for early detection of bird flu

Q&A: Optometrists ‘on the frontlines’ for early detection of bird flu

According to the CDC, H5N1 bird flu has caused recent outbreaks in poultry and dairy cows, with a total of four human cases reported among U.S. dairy and poultry workers. In at least two cases, the only reported symptom was red eyes.

SPONSORED CONTENT
July 02, 2024
1 min read
Save

FDA approves Eylea biosimilar FYB203/Ahzantive

FDA approves Eylea biosimilar FYB203/Ahzantive

The FDA approved FYB203/Ahzantive as a biosimilar to Eylea, according to a joint press release from Formycon and Klinge Biopharma.

SPONSORED CONTENT
July 02, 2024
2 min watch
Save

VIDEO: NT-501 reduces progression of macular telangiectasia type 2

VIDEO: NT-501 reduces progression of macular telangiectasia type 2

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Thomas Aaberg Jr., MD, of Neurotech Pharmaceuticals, discusses NT-501, an encapsulated cell therapy in development for macular telangiectasia type 2.

SPONSORED CONTENT
July 02, 2024
3 min read
Save

‘Ho-ho, ha-ha-ha!’ Try laughter yoga to improve well-being

‘Ho-ho, ha-ha-ha!’ Try laughter yoga to improve well-being

To combat the myriad of stressors in life, taking a break to plug into your inner joy opens the door to increased well-being.

SPONSORED CONTENT
July 01, 2024
1 min read
Save

Endoscopic and external dacryocystorhinostomy show comparable outcomes

Endoscopic and external dacryocystorhinostomy show comparable outcomes

KIAWAH ISLAND, S.C. — A study presented at Kiawah Eye found no difference in surgical outcomes between endoscopic and external dacryocystorhinostomy in adults and children with nasolacrimal duct obstruction.

SPONSORED CONTENT
July 01, 2024
4 min read
Save

BLOG: Considerations for expanding the scope of optometry

BLOG: Considerations for expanding the scope of optometry

As a past president of the Pennsylvania Optometric Association, I am very familiar with how our profession expands its scope of practice.

SPONSORED CONTENT
July 01, 2024
1 min read
Save

Real-world data show Luminopia improves visual acuity in children with amblyopia

Real-world data show Luminopia improves visual acuity in children with amblyopia

Digital health company Luminopia Inc. announced real-world data from the Patients Using Prescription Luminopia Registry, which demonstrated the efficacy of its binocular, virtual reality-based medical device for children with amblyopia.

SPONSORED CONTENT
July 01, 2024
2 min watch
Save

VIDEO: 4D Molecular Therapeutics shares update on retinal disease candidates

VIDEO: 4D Molecular Therapeutics shares update on retinal disease candidates

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, David Kirn, MD, of 4D Molecular Therapeutics provides an update on two candidates for retinal diseases.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails